|
chip
|
BAO_0010023 |
|
|
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
|
CHEBI_78622 |
|
|
regulation of molecular function
|
GO_0065009 |
|
|
agarose gel
|
BAO_0010020 |
|
|
bone morphogenetic protein receptor antagonist
|
CHEBI_78623 |
|
|
P100 protein profiling assay
|
BAO_0010029 |
|
|
preclinical development stage
|
BAO_0010025 |
|
|
SWATH MS protein profiling assay
|
BAO_0010028 |
|
|
shotgun MS protein profiling assay
|
BAO_0010027 |
|
|
specialised pro-resolving mediator
|
CHEBI_140399 |
|
|
cells per milliliter
|
UO_0000201 |
|
|
catalytic (activity) concentration unit
|
UO_0000202 |
|
|
plasma stability with inhibitors
|
BAO_0010099 |
|
|
whole blood stability assay
|
BAO_0010098 |
|
|
katal per cubic meter
|
UO_0000203 |
|
|
katal per liter
|
UO_0000204 |
|
|
drug metabolism assay
|
BAO_0010090 |
|
|
portal vein study
|
BAO_0010094 |
|
|
S9 stability assay
|
BAO_0010097 |
|
|
cytosol stability assay
|
BAO_0010096 |
|
